Abstract
The CUB domain-containing protein-1 (CDCP1) is a transmembrane molecule that has recently been implicated in cancer progression. In this study we have established a novel mechanism for initiation of CDCP1-mediated signaling in vivo and demonstrated that specific 135→70-kDa processing of cell-surface CDCP1 by extracellular serine proteases is a prerequisite for CDCP1-dependent survival of cancer cells during metastasis. The in vivo cleavage of CDCP1 triggers a survival program involving recruitment of Src and PKCδ, Src-mediated phosphorylation of cell-surface-retained 70-kDa CDCP1, activation of Akt and suppression of PARP1-induced apoptosis. We demonstrate in vivo that phosphorylated Src, PKCδ and Akt all constitute activated elements of a CDCP1-signaling axis during tissue colonization of tumor cells. Preventing in vivo cleavage of CDCP1 with unique anti-CDCP1 antibodies, serine protease inhibitors or genetic modulation of the cleavage site in the CDCP1 molecule completely abrogated survival signaling associated with the 70-kDa CDCP1, and induced PARP1 cleavage and PARP1-mediated apoptosis, ultimately resulting in substantial inhibition of tissue colonization by tumor cells. The lack of CDCP1 cleavage in the lung tissue of plasminogen-knockout mice along with a coordinated reduction in tumor cell survival in a lung retention model, and importantly rescue of both by in vivo supplied plasmin, indicated that plasmin is the crucial serine protease executing in vivo cleavage of cell-surface CDCP1 during early stages of lung colonization. Together, our findings indicate that in vivo blocking of CDCP1 cleavage upstream from CDCP1-induced pro-survival signaling provides a potential mechanism for therapeutic intervention into metastatic disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK et al. (2004). AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 23: 5853–5857.
Alvares SM, Dunn CA, Brown TA, Wayner EE, Carter WG . (2008). The role of membrane microdomains in transmembrane signaling through the epithelial glycoprotein Gp140/CDCP1. Biochim Biophys Acta 1780: 486–496.
Awakura Y, Nakamura E, Takahashi T, Kotani H, Mikami Y, Kadowaki T et al. (2008). Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma. J Cancer Res Clin Oncol 134: 1363–1369.
Benes CH, Poulogiannis G, Cantley LC, Soltoff SP . (2011). The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility. Oncogene (e-pub ahead of print 4 July 2011; doi:10.1038/onc.2011.262).
Benes CH, Wu N, Elia AE, Dharia T, Cantley LC, Soltoff SP . (2005). The C2 domain of PKCdelta is a phosphotyrosine binding domain. Cell 121: 271–280.
Bhatt AS, Erdjument-Bromage H, Tempst P, Craik CS, Moasser MM . (2005). Adhesion signaling by a novel mitotic substrate of src kinases. Oncogene 24: 5333–5343.
Brown TA, Yang TM, Zaitsevskaia T, Xia Y, Dunn CA, Sigle RO et al. (2004). Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia. J Biol Chem 279: 14772–14783.
Chaitanya GV, Steven AJ, Babu PP . (2010). PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal 8: 31.
Conn EM, Botkjaer KA, Kupriyanova TA, Andreasen PA, Deryugina EI, Quigley JP . (2009). Comparative analysis of metastasis variants derived from human prostate carcinoma cells. Roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion. Am J Pathol 175: 1638–1652.
Coughlin SR . (2000). Thrombin signalling and protease-activated receptors. Nature 407: 258–264.
Deryugina EI, Conn EM, Wortmann A, Partridge JJ, Kupriyanova TA, Ardi VC et al. (2009). Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination. Mol Cancer Res 7: 1197–1211.
Deryugina EI, Ratnikov BI, Postnova TI, Rozanov DV, Strongin AY . (2002). Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem 277: 9749–9756.
Gobeil S, Boucher CC, Nadeau D, Poirier GG . (2001). Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ 8: 588–594.
Gray K, Ellis V . (2008). Activation of pro-BDNF by the pericellular serine protease plasmin. FEBS Lett 582: 907–910.
He Y, Wortmann A, Burke LJ, Reid JC, Adams MN, Abdul-Jabbar I et al. (2010). Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta. J Biol Chem 285: 26162–26173.
Hooper JD, Zijlstra A, Aimes RT, Liang H, Claassen GF, Tarin D et al. (2003). Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen. Oncogene 22: 1783–1794.
Landis RC, Asimakopoulos G, Poullis M, Haskard DO, Taylor KM . (2001). The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg 72: 2169–2175.
Liu H, Ong SE, Badu-Nkansah K, Schindler J, White FM, Hynes RO . (2011). CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis. Proc Natl Acad Sci USA 108: 1379–1384.
Miyazawa Y, Uekita T, Hiraoka N, Fujii S, Kosuge T, Kanai Y et al. (2010). CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res 70: 5136–5146.
Nam S, Kim D, Cheng JQ, Zhang S, Lee JH, Buettner R et al. (2005). Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Cancer Res 65: 9185–9189.
Razorenova OV, Finger EC, Colavitti R, Chernikova SB, Boiko AD, Chan CK et al. (2011). VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKCdelta-driven migration. Proc Natl Acad Sci USA 108: 1931–1936.
Schmidt A, Echtermeyer F, Alozie A, Brands K, Buddecke E . (2005). Plasmin- and thrombin-accelerated shedding of syndecan-4 ectodomain generates cleavage sites at Lys(114)–Arg(115) and Lys(129)–Val(130) bonds. J Biol Chem 280: 34441–34446.
Shi X, Gangadharan B, Brass LF, Ruf W, Mueller BM . (2004). Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2: 395–402.
Spassov DS, Wong CH, Moasser MM . (2011a). Trask phosphorylation defines the reverse mode of a phosphotyrosine signaling switch that underlies cell anchorage state. Cell Cycle 10: 1225–1232.
Spassov DS, Wong CH, Sergina N, Ahuja D, Fried M, Sheppard D et al. (2011b). Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling. Mol Cell Biol 31: 766–782.
Uekita T, Jia L, Narisawa-Saito M, Yokota J, Kiyono T, Sakai R . (2007). CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma. Mol Cell Biol 27: 7649–7660.
Uekita T, Tanaka M, Takigahira M, Miyazawa Y, Nakanishi Y, Kanai Y et al. (2008). CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma. Am J Pathol 172: 1729–1739.
Wortmann A, He Y, Christensen ME, Linn M, Lumley JW, Pollock PM et al. (2011). Cellular settings mediating Src substrate switching between focal adhesion kinase (FAK) tyrosine 861 and CUB-domain containing protein 1 (CDCP1) tyrosine 734. J Biol Chem, (in press; accessible online at http://www.jbc.org/cgi/doi/10.1074/jbc.M111.227462).
Wortmann A, He Y, Deryugina EI, Quigley JP, Hooper JD . (2009). The cell surface glycoprotein CDCP1 in cancer—insights, opportunities, and challenges. IUBMB Life 61: 723–730.
Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M et al. (2009). Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16: 67–78.
Acknowledgements
We thank Drs Frank Castellino and Victoria Ploplis for providing the breeding pair of plasminogen-KO mice. We also thank Dr Lindsey Miles for insightful suggestions, and originally procuring and housing the plasminogen-KO mice. This study was supported by NIH Grants R01 CA 129484 and R01 CA 105412 (to JPQ), NIH/NCRR/STSI Grant RR 025774 (Pilot Award to EID), Postdoctoral Fellowship from the Science and Innovation Ministry of Spain (to BC), and the National Health and Medical Research Council of Australia (Fellowship 339732 to JDH).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Casar, B., He, Y., Iconomou, M. et al. Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells. Oncogene 31, 3924–3938 (2012). https://doi.org/10.1038/onc.2011.555
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.555
Keywords
This article is cited by
-
Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
Journal of Hematology & Oncology (2022)
-
Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma
Cancer Cell International (2022)
-
lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma
Cell Death & Disease (2022)
-
The role of E3 ubiquitin ligase WWP2 and the regulation of PARP1 by ubiquitinated degradation in acute lymphoblastic leukemia
Cell Death Discovery (2022)
-
AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer
Scientific Reports (2022)